Cerity Partners
BBIO icon

Cerity Partners’s BridgeBio Pharma BBIO Stock Holding History

Cerity Partners’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Buy
27,128
+6,533
+32% +$458K ﹤0.01% 1590
2026
Q1 		$1.53M Buy
20,595
+14,925
+263% +$1.08M ﹤0.01% 1616
2025
Q4 		$434K Buy
5,670
+37
+0.7% +$2.43K ﹤0.01% 2195
2025
Q3 		$293K Sell
5,633
-969
-15% -$47.3K ﹤0.01% 2292
2025
Q2 		$285K Sell
6,602
-16
-0.2% -$582 ﹤0.01% 2176
2025
Q1 		$229K Buy
+6,618
New +$223K ﹤0.01% 2152

Other funds holding BBIO

JTL
Jupiter Topco LLC New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Cerity Partners's BBIO Position: Q2 2026 in Review

Cerity Partners increased its BridgeBio Pharma (BBIO) stake by 32% in Q2 2026, buying an estimated $458K and bringing the position to 27,128 shares worth $2.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1590.

Cerity Partners first reported a position in BBIO in Q1 2025 and has held it in 6 quarters since. 439 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Cerity Partners held 27,128 shares of BridgeBio Pharma worth $2.02M as of Q2 2026.
  • Cerity Partners bought 6,533 BridgeBio Pharma shares in Q2 2026, an estimated $458K.
  • BridgeBio Pharma made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1590 holding.
  • Cerity Partners first reported a position in BridgeBio Pharma in Q1 2025 and has held it in 6 quarters since.
  • 439 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.